Fundraising Fox
🦊/People
Sign in

Steven Biesmans

Investor

Principal at UCB Ventures

Brussels Metropolitan Area

Find your path to Steven

70 people in our graph share verified history with Steven — schools, employers, funds. One of them is your warm intro.

Perry NisenunlockedSteven: together at Sanford Burnham Prebys Medical Discovery Institute (2014–2017)
×4Steven: together at Janssen, Pharmaceutical Companies of Johnson and Johnson
×4Steven: together at RWTH Aachen University
×3Steven: together at Hasselt University

About

Steven Biesmans is a Principal (Director) at UCB Ventures, the corporate venture arm of UCB Pharma, where he focuses on early-stage investment opportunities in next-generation therapeutics and scientific innovation. He holds a Ph.D. in Neuroimmunology and has more than 12 years of experience in preclinical drug discovery, having developed technology platforms and managed scientific programs across academic, biotech, and pharmaceutical settings in Europe and the United States.

Contact· self-published, not guessed

Experience

  1. UCBPrincipal (Director) at UCB Venturescurrent2021 — presentBrussels, Brussels Region, Belgium
  2. UCBSenior Scientist2018 — 2021Brussels Metropolitan Area
  3. StemoniXSenior Scientist2017 — 2018San Diego County, California, United States
  4. Sanford Burnham Prebys Medical Discovery InstitutePostdoctoral Associate2014 — 2017San Diego County, California, United States
  5. Transnational University Limburg / Janssen R&DPhD Candidate2010 — 2014Hasselt University / Janssen R&D (Belgium)
  6. RWTH Aachen UniversityContract Researcher2009 — 2010Aachen, Germany
  7. Janssen, Pharmaceutical Companies of Johnson and JohnsonIntern2008 — 2009Janssen R&D (Belgium)

Skills & more

NegotiationValuation2Biotechnology1PharmaceuticalLife Science IndustryDCF Valuation1Neuroscience30Immunology8Behavioral Neuroscience4Molecular Neuroscience2Imaging Science3Cytokines4
+12 morert-qPCRImmunohistochemistryRadiolabelingNeurodegenerationqPCRAnimal ModelsIn VitroMicroscopyIn VivorNPV valuationrNPV valuationLicensing deal structuring

Languages Dutch · English · French · German · Portuguese

  • Venture Capital — Wharton Executive Education
  • Leadership Mastery Program — IMD
  • Modelling Inflammation with iPS-Macrophages and Microglia — University of Oxford
  • The Art of Science Communication — American Society for Biochemistry and Molecular Biology (ASBMB)
  • International Leadership and Organizational Behavior — Coursera

From Steven's professional profile.

Colleagues at UCB Ventures

Alicia Irurzun-Lafitte
Partner at UCB Ventures
Erica Whittaker
Head of UCB Ventures at UCB Ventures
Rahul Khetan
Venture Associate at UCB Ventures
Reiner Class
Analyst at UCB Ventures

Frequently asked questions

Who is Steven Biesmans?
Steven Biesmans is a Principal (Director) at UCB Ventures, the corporate venture arm of UCB Pharma, where he focuses on early-stage investment opportunities in next-generation therapeutics and scientific innovation. He holds a Ph.D. in Neuroimmunology and has more than 12 years of experience in preclinical drug discovery, having developed technology platforms and managed scientific programs across academic, biotech, and pharmaceutical settings in Europe and the United States.
Where does Steven Biesmans work?
Steven Biesmans is Principal at UCB Ventures.
Where did Steven Biesmans go to school?
Steven Biesmans studied at Transnational University Limburg (Doctor of Philosophy (Ph.D.), Biomedical Sciences); CELforPharma (Pharma-Biotech Product & Company Valuation); Hasselt University (Master of Science (M.Sc.), Clinical Molecular Sciences).

Same school

Shared employers